Indian pharma industry needs a winning partnership
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
ICICI Direct’s analysis of Cipla’s Q3FY22 results
It is the generic version of molnupiravir
First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age
It plans to deliver over 300 million doses to the Indian government
Flattish volume growth and subdued new launches were key factors for last month
2022 is going to be the year of opportunities and innovations from the medical industry in India
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
Subscribe To Our Newsletter & Stay Updated